Table of Content

1 Vaccines Market Overview
1.1 Vaccines Product Scope
1.2 Vaccines Segment by Type
1.2.1 Global Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines Segment by Application
1.3.1 Global Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cholera
1.3.3 Hepatitis B
1.3.4 Diphtheria
1.3.5 Tetanus
1.3.6 Measles Vaccine
1.3.7 Hepatitis A
1.3.8 Live Attenuated Influenza Vaccine
1.3.9 Polio Vaccine
1.3.10 Rabies Vaccine
1.4 Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Vaccines Price Trends (2016-2027)

2 Vaccines Estimates and Forecasts by Region
2.1 Global Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Vaccines Estimates and Projections (2016-2027)
2.4.3 China Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Vaccines Estimates and Projections (2016-2027)
2.4.6 India Vaccines Estimates and Projections (2016-2027)
3 Global Vaccines Competition Landscape by Players
3.1 Global Top Vaccines Players by Sales (2016-2021)
3.2 Global Top Vaccines Players by Revenue (2016-2021)
3.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccines as of 2020)
3.4 Global Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Vaccines Market Size by Type
4.1 Global Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Vaccines Price by Type (2016-2021)
4.2 Global Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Vaccines Price Forecast by Type (2022-2027)
5 Global Vaccines Market Size by Application
5.1 Global Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Vaccines Price by Application (2016-2021)
5.2 Global Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Vaccines Price Forecast by Application (2022-2027)

6 North America Vaccines Market Facts & Figures
6.1 North America Vaccines Sales by Company
6.1.1 North America Vaccines Sales by Company (2016-2021)
6.1.2 North America Vaccines Revenue by Company (2016-2021)
6.2 North America Vaccines Sales Breakdown by Type
6.2.1 North America Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Vaccines Sales Breakdown by Application
6.3.1 North America Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Vaccines Market Facts & Figures
7.1 Europe Vaccines Sales by Company
7.1.1 Europe Vaccines Sales by Company (2016-2021)
7.1.2 Europe Vaccines Revenue by Company (2016-2021)
7.2 Europe Vaccines Sales Breakdown by Type
7.2.1 Europe Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Vaccines Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Vaccines Market Facts & Figures
8.1 China Vaccines Sales by Company
8.1.1 China Vaccines Sales by Company (2016-2021)
8.1.2 China Vaccines Revenue by Company (2016-2021)
8.2 China Vaccines Sales Breakdown by Type
8.2.1 China Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Vaccines Sales Breakdown by Application
8.3.1 China 317 Sales Breakdown by Application (2016-2021)
8.3.2 China 317 Sales Breakdown by Application (2022-2027)

9 Japan Vaccines Market Facts & Figures
9.1 Japan Vaccines Sales by Company
9.1.1 Japan Vaccines Sales by Company (2016-2021)
9.1.2 Japan Vaccines Revenue by Company (2016-2021)
9.2 Japan Vaccines Sales Breakdown by Type
9.2.1 Japan Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Vaccines Market Facts & Figures
10.1 Southeast Asia Vaccines Sales by Company
10.1.1 Southeast Asia Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Vaccines Market Facts & Figures
11.1 India Vaccines Sales by Company
11.1.1 India Vaccines Sales by Company (2016-2021)
11.1.2 India Vaccines Revenue by Company (2016-2021)
11.2 India Vaccines Sales Breakdown by Type
11.2.1 India Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Vaccines Sales Breakdown by Application
11.3.1 India Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Vaccines Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Vaccines Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Business Overview
12.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Vaccines Products Offered
12.2.5 Sanofi Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Vaccines Products Offered
12.4.5 Pfizer Recent Development
12.5 Novartis(GSK)
12.5.1 Novartis(GSK) Corporation Information
12.5.2 Novartis(GSK) Business Overview
12.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novartis(GSK) Vaccines Products Offered
12.5.5 Novartis(GSK) Recent Development
12.6 CSL
12.6.1 CSL Corporation Information
12.6.2 CSL Business Overview
12.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CSL Vaccines Products Offered
12.6.5 CSL Recent Development
12.7 MedImmune LLC
12.7.1 MedImmune LLC Corporation Information
12.7.2 MedImmune LLC Business Overview
12.7.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 MedImmune LLC Vaccines Products Offered
12.7.5 MedImmune LLC Recent Development
12.8 J&J(Crucell)
12.8.1 J&J(Crucell) Corporation Information
12.8.2 J&J(Crucell) Business Overview
12.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 J&J(Crucell) Vaccines Products Offered
12.8.5 J&J(Crucell) Recent Development
12.9 China National Biotec
12.9.1 China National Biotec Corporation Information
12.9.2 China National Biotec Business Overview
12.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China National Biotec Vaccines Products Offered
12.9.5 China National Biotec Recent Development
12.10 Tiantan
12.10.1 Tiantan Corporation Information
12.10.2 Tiantan Business Overview
12.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Tiantan Vaccines Products Offered
12.10.5 Tiantan Recent Development
12.11 Hualan
12.11.1 Hualan Corporation Information
12.11.2 Hualan Business Overview
12.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hualan Vaccines Products Offered
12.11.5 Hualan Recent Development
12.12 Kangtai
12.12.1 Kangtai Corporation Information
12.12.2 Kangtai Business Overview
12.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Kangtai Vaccines Products Offered
12.12.5 Kangtai Recent Development
12.13 Hissen
12.13.1 Hissen Corporation Information
12.13.2 Hissen Business Overview
12.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Hissen Vaccines Products Offered
12.13.5 Hissen Recent Development
12.14 Jintan
12.14.1 Jintan Corporation Information
12.14.2 Jintan Business Overview
12.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Jintan Vaccines Products Offered
12.14.5 Jintan Recent Development

13 Vaccines Manufacturing Cost Analysis
13.1 Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vaccines
13.4 Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vaccines Distributors List
14.3 Vaccines Customers

15 Market Dynamics
15.1 Vaccines Market Trends
15.2 Vaccines Drivers
15.3 Vaccines Market Challenges
15.4 Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Vaccines Sales (K Pcs) by Region (2016-2021)
Table 5. Global Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Vaccines Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Vaccines Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Vaccines Sales Share by Company (2016-2021)
Table 14. Global Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines as of 2020)
Table 17. Global Vaccines Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Vaccines Sales (K Pcs) by Type (2016-2021)
Table 22. Global Vaccines Sales Share by Type (2016-2021)
Table 23. Global Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Vaccines Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Vaccines Sales Share by Type (2022-2027)
Table 26. Global Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Vaccines Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Vaccines Sales (K Pcs) by Application (2016-2021)
Table 30. Global Vaccines Sales Share by Application (2016-2021)
Table 31. Global Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Vaccines Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Vaccines Sales (K Pcs) by Application (2022-2027)
Table 34. Global Vaccines Sales Share by Application (2022-2027)
Table 35. Global Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Vaccines Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Vaccines Sales (K Pcs) by Company (2016-2021)
Table 39. North America Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Vaccines Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Vaccines Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Vaccines Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Vaccines Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Vaccines Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Vaccines Sales (K Pcs) by Company (2016-2021)
Table 63. China Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 67. China Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Vaccines Sales by Type (2022-2027) & (K Pcs)
Table 69. China Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 71. China Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Vaccines Sales by Application (2022-2027) & (K Pcs)
Table 73. China Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Vaccines Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Vaccines Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Vaccines Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Vaccines Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Vaccines Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Vaccines Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Vaccines Sales (K Pcs) by Company (2016-2021)
Table 99. India Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 103. India Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Vaccines Sales by Type (2022-2027) & (K Pcs)
Table 105. India Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 107. India Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Vaccines Sales by Application (2022-2027) & (K Pcs)
Table 109. India Vaccines Sales Market Share by Application (2022-2027)
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. GSK Vaccines Product
Table 114. GSK Recent Development
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Sanofi Vaccines Product
Table 119. Sanofi Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Merck Vaccines Product
Table 124. Merck Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Pfizer Vaccines Product
Table 129. Pfizer Recent Development
Table 130. Novartis(GSK) Corporation Information
Table 131. Novartis(GSK) Description and Business Overview
Table 132. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Novartis(GSK) Vaccines Product
Table 134. Novartis(GSK) Recent Development
Table 135. CSL Corporation Information
Table 136. CSL Description and Business Overview
Table 137. CSL Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. CSL Vaccines Product
Table 139. CSL Recent Development
Table 140. MedImmune LLC Corporation Information
Table 141. MedImmune LLC Description and Business Overview
Table 142. MedImmune LLC Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. MedImmune LLC Vaccines Product
Table 144. MedImmune LLC Recent Development
Table 145. J&J(Crucell) Corporation Information
Table 146. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. J&J(Crucell) Description and Business Overview
Table 148. J&J(Crucell) Vaccines Product
Table 149. J&J(Crucell) Recent Development
Table 150. China National Biotec Corporation Information
Table 151. China National Biotec Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. China National Biotec Description and Business Overview
Table 153. China National Biotec Vaccines Product
Table 154. China National Biotec Recent Development
Table 155. Tiantan Corporation Information
Table 156. Tiantan Description and Business Overview
Table 157. Tiantan Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Tiantan Vaccines Product
Table 159. Tiantan Recent Development
Table 160. Hualan Corporation Information
Table 161. Hualan Description and Business Overview
Table 162. Hualan Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Hualan Vaccines Product
Table 164. Hualan Recent Development
Table 165. Kangtai Corporation Information
Table 166. Kangtai Description and Business Overview
Table 167. Kangtai Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Kangtai Vaccines Product
Table 169. Kangtai Recent Development
Table 170. Hissen Corporation Information
Table 171. Hissen Description and Business Overview
Table 172. Hissen Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Hissen Vaccines Product
Table 174. Hissen Recent Development
Table 175. Jintan Corporation Information
Table 176. Jintan Description and Business Overview
Table 177. Jintan Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Jintan Vaccines Product
Table 179. Jintan Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Vaccines Distributors List
Table 183. Vaccines Customers List
Table 184. Vaccines Market Trends
Table 185. Vaccines Market Drivers
Table 186. Vaccines Market Challenges
Table 187. Vaccines Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines Product Picture
Figure 2. Global Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Cholera Examples
Figure 7. Hepatitis B Examples
Figure 8. Diphtheria Examples
Figure 9. Tetanus Examples
Figure 10. Measles Vaccine Examples
Figure 11. Hepatitis A Examples
Figure 12. Live Attenuated Influenza Vaccine Examples
Figure 13. Polio Vaccine Examples
Figure 14. Rabies Vaccine Examples
Figure 15. Global Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 17. Global Vaccines Sales (K Pcs) Growth Rate (2016-2027)
Figure 18. Global Vaccines Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 19. Global Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 20. Global Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 21. North America Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. North America Vaccines Sales (K Pcs) Growth Rate (2016-2027)
Figure 23. Europe Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Europe Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 25. China Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. China Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 27. Japan Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Japan Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 31. India Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 32. India Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 33. Global 5 Largest Vaccines Players Market Share by Revenue in Vaccines: 2016 & 2020
Figure 34. Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 35. Global Vaccines Revenue Share by Type (2016-2021)
Figure 36. Global Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Global Vaccines Revenue Share by Application (2016-2021)
Figure 38. Global Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Vaccines Sales Market Share by Type in 2020
Figure 40. North America Vaccines Sales Market Share by Application in 2020
Figure 41. Europe Vaccines Sales Market Share by Type in 2020
Figure 42. Europe Vaccines Sales Market Share by Application in 2020
Figure 43. China Vaccines Sales Market Share by Type in 2020
Figure 44. China Vaccines Sales Market Share by Application in 2020
Figure 45. Japan Vaccines Sales Market Share by Type in 2020
Figure 46. Japan Vaccines Sales Market Share by Application in 2020
Figure 47. Southeast Asia Vaccines Sales Market Share by Type in 2020
Figure 48. Southeast Asia Vaccines Sales Market Share by Application in 2020
Figure 49. India Vaccines Sales Market Share by Type in 2020
Figure 50. India Vaccines Sales Market Share by Application in 2020
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Vaccines
Figure 53. Manufacturing Process Analysis of Vaccines
Figure 54. Vaccines Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed